Have a feature idea you'd love to see implemented?
Let us know!
NEPH Nephros Inc
Price (delayed)
$1.51
Market cap
$15.92M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.09
Enterprise value
$14.96M
Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Its diverse team of passionate employees are dedicated to advancing
Highlights
The company's quick ratio has surged by 54% QoQ and by 18% YoY
The EPS has soared by 50% YoY and by 31% from the previous quarter
The company's debt has surged by 91% YoY but it fell by 6% QoQ
Nephros's equity has decreased by 5% YoY but it has increased by 3.1% QoQ
Key stats
What are the main financial stats of NEPH
Market
Valuations
Earnings
Shares outstanding
10.54M
Market cap
$15.92M
Enterprise value
$14.96M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.95
Price to sales (P/S)
1.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
Revenue
$13.55M
EBIT
-$927,000
EBITDA
-$774,000
Free cash flow
-$2.11M
Per share
Balance sheet
Liquidity
EPS
-$0.09
Free cash flow per share
-$0.2
Book value per share
$0.78
Revenue per share
$1.28
TBVPS
$0.86
Total assets
$10.39M
Total liabilities
$2.21M
Debt
$1.49M
Equity
$8.17M
Working capital
$6.3M
Debt to equity
0.18
Current ratio
6.95
Quick ratio
3.92
Net debt/EBITDA
1.25
Margins
Efficiency
Dividend
EBITDA margin
-5.7%
Gross margin
61%
Net margin
-6.9%
Operating margin
-7.1%
Return on assets
-8.3%
Return on equity
-11.4%
Return on invested capital
-14.6%
Return on capital employed
-9.9%
Return on sales
-6.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NEPH stock price
How has the Nephros stock price performed over time
Intraday
0.67%
1 week
-3.21%
1 month
5.42%
1 year
-32.59%
YTD
-56.36%
QTD
-11.7%
Financial performance
How have Nephros's revenue and profit performed over time
Revenue
$13.55M
Gross profit
$8.27M
Operating income
-$960,000
Net income
-$929,000
Gross margin
61%
Net margin
-6.9%
Nephros's net income has increased by 49% YoY and by 28% from the previous quarter
The company's net margin rose by 49% YoY and by 27% QoQ
The company's operating income rose by 41% YoY and by 30% QoQ
The operating margin rose by 41% YoY and by 28% QoQ
Growth
What is Nephros's growth rate over time
Valuation
What is Nephros stock price valuation
P/E
N/A
P/B
1.95
P/S
1.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
The EPS has soared by 50% YoY and by 31% from the previous quarter
NEPH's price to book (P/B) is 60% less than its 5-year quarterly average of 4.9 and 35% less than its last 4 quarters average of 3.0
Nephros's equity has decreased by 5% YoY but it has increased by 3.1% QoQ
The price to sales (P/S) is 73% lower than the 5-year quarterly average of 4.4 and 34% lower than the last 4 quarters average of 1.8
Efficiency
How efficient is Nephros business performance
Nephros's ROIC has soared by 63% YoY and by 38% from the previous quarter
The ROE has soared by 51% YoY and by 27% from the previous quarter
The return on assets has surged by 51% year-on-year and by 27% since the previous quarter
The ROS has soared by 50% YoY and by 28% from the previous quarter
Dividends
What is NEPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NEPH.
Financial health
How did Nephros financials performed over time
The current ratio has soared by 71% QoQ and by 49% YoY
The company's quick ratio has surged by 54% QoQ and by 18% YoY
The company's debt is 82% lower than its equity
The debt to equity has surged by 100% year-on-year but it has declined by 10% since the previous quarter
The company's debt has surged by 91% YoY but it fell by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.